Avista Capital Partners III GP L.P. 13D and 13G filings for RVL Pharmaceuticals plc:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-08-09 5:20 pm Purchase | 2022-08-08 | 13D | RVL Pharmaceuticals plc RVLPQ | Avista Capital Partners III GP L.P. | 23,730,864 24.000% | 8,000,000 (+50.86%) | Filing |
| 2021-10-14 4:10 pm Unchanged | 2021-10-12 | 13D | RVL Pharmaceuticals plc RVLPQ | Avista Capital Partners III GP L.P. | 15,730,864 18.900% | 0 (Unchanged) | Filing |